newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today the results of a second U.S. Food a